Table 3.

Multiple regression resultsa

Water contentProton density
Adjusted R2R2 changeFpAdjusted R2R2 changeFp
Gray matter decreases in patients compared with control
    PCC R
        BPND0.350.063.20.0820.530.063.20.082
        T1/PD0.20b12.7b0.001b0.40b35.5b<0.001b
        Group0.12b9.2b0.004b0.08b8.3b0.006b
        Group × BPND0.042.80.1020.043.90.055
        Group × T1/PD0.000.10.7300.000.00.961
    Fusiform R
        BPND0.010.40.5090.330.010.40.509
        T1/PD0.010.60.4520.042.10.158
        Group0.31b21.2b<0.001b0.3021.2b<0.001b
        Group × BPND0.021.40.2490.021.30.253
        Group × T1/PD0.053.80.0580.032.20.141
    Insula L
        BPND0.310.11b5.9b0.018b0.380.11b5.9b0.018b
        T1/PD0.15b9.8b0.003b0.23b16.6b<0.001b
        Group0.11b8.1b0.007b0.08b6.1b0.017b
        Group × BPND0.010.40.5150.000.30.585
        Group × T1/PD0.000.10.8200.022.00.168
    Insula R
        BPND0.340.063.40.0720.420.063.40.072
        T1/PD0.23b15.3b<0.001b0.29b21.8b<0.001b
        Group0.11b8.9b0.005b0.10b8.3b0.006b
        Group × BPND0.000.10.7020.011.10.298
        Group × T1/PD0.000.10.7860.010.80.377
    MPFC R
        BPND0.680.12b6.6b0.013b0.770.12b6.6b0.013b
        T1/PD0.55b79.3b<0.001b0.65b131.1b<0.001b
        Group0.04b6.5b0.014b0.03b6.2b0.016b
        Group × BPND0.011.00.3260.000.30.578
        Group × T1/PD0.000.30.5940.000.90.347
    ACC L
        BPND0.290.000.00.9300.320.000.00.930
        T1/PD0.13b6.9b0.012b0.20b11.8b0.001b
        Group0.21b14.6b<0.001b0.16b11.9b0.001b
        Group × BPND0.021.60.2060.031.90.180
        Group × T1/PD0.000.00.8610.000.20.695
    Precuneus R
        BPND0.620.020.80.3760.590.020.80.376
        T1/PD0.42b35.1b<0.001b0.41b34.0b<0.001b
        Group0.15b17.3b<0.001b0.15b16.8b<0.001b
        Group × BPND0.06b7.3b0.010b0.05b5.8b0.020b
        Group × T1/PD0.022.00.1680.010.70.398
    Precentral L
        BPND0.380.000.00.9250.400.000.00.925
        T1/PD0.36b27.3b<0.001b0.40b31.3b<0.001b
        Group0.06b4.8b0.033b0.043.70.061
        Group × BPND0.021.40.2490.021.40.246
        Group × T1/PD0.000.20.6500.000.00.828
    MTG L
        BPND0.450.12b6.5b0.014b0.450.12b6.5b0.014b
        T1/PD0.34b30.0b<0.001b0.35b31.0b<0.001b
        Group0.032.60.1160.032.80.098
        Group × BPND0.010.50.4710.010.50.505
        Group × T1/PD0.010.90.3540.010.60.431
Gray matter increases in patients compared with controls
    Angular gyrus L
        BPND0.560.32b22.7b<0.001b0.610.32b22.7b<0.001b
        T1/PD0.22b22.0b<0.001b0.28b34.0b<0.001b
        Group0.06b6.4b0.015b0.04b4.6b0.038b
        Group × BPND0.000.00.8990.010.60.439
        Group × T1/PD0.011.50.2250.010.60.430
    Cuneus R
        BPND0.810.70b114.0b<0.001b0.870.70b114.0b<0.001b
        T1/PD0.12b33.7b<0.001b0.17b65.6b<0.001b
        Group0.001.00.3240.001.10.298
        Group × BPND0.000.90.3580.012.00.160
        Group × T1/PD0.000.10.7940.000.10.795
    Postcentral gyrus R
        BPND0.400.22b13.6b0.001b0.470.22b13.6b0.001b
        T1/PD0.18b14.6b<0.001b0.24b20.7b<0.001b
        Group0.05b4.5b0.039b0.043.70.059
        Group × BPND0.010.50.4910.010.60.447
        Group × T1/PD0.010.40.5310.032.40.130
  • aGMV served as the dependent variable; flumazenil BPND, T1 time (water content) or proton density (PD), group (patients or controls), and the interaction terms served as the explanatory variables in the multiple regression analysis. L, Left; R, right.

  • bSignificant with cluster-level correction across the whole brain at p < 0.05.